Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Craig Hettenbach
MS
Craig Hettenbach
Wall Street Analyst
★★★☆☆
#1494
on 13Foresight · ranked by our own returns
55%
Success Rate
+3.4%
Average Return
23 of 42 calls profitable · -2013.0% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 55% of Craig Hettenbach's ratings turned a profit when each position was held for 1 year — averaging +3.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

47 Buy 57 Hold 8 Sell
Craig's Stock Coverage 39 ratings · 2026-06-20
Company Date Position Consensus Price Target 1-Yr Return
THC
Tenet Healthcare
Jun 15, 2026 BUY Strong Buy
+25.9% avg upside
26 analysts
$254.00
47.25% Upside
-0.3%
HNGE
Hinge Health, Inc. Class A
Jun 11, 2026 BUY Strong Buy
+7.2% avg upside
17 analysts
$72.00
3.80% Upside
+3.5%
GMRS
GMR Solutions, Inc. Class A
Jun 09, 2026 HOLD Strong Buy
+47.6% avg upside
8 analysts
$14.00
5.65% Upside
·
ARDT
Ardent Health Partners, Inc.
Jun 08, 2026 HOLD Buy
+53.2% avg upside
16 analysts
$12.00
34.71% Upside
+2.8%
VEEV
Veeva Systems
Jun 04, 2026 HOLD Strong Buy
+54.2% avg upside
36 analysts
$215.00
40.18% Upside
-5.5%
WAY
Waystar Holding Corp.
May 27, 2026 HOLD Strong Buy
+105.7% avg upside
29 analysts
-3.4%
UHS
Universal Health
May 21, 2026 HOLD Buy
+50.5% avg upside
22 analysts
$212.00
50.27% Upside
-12.9%
OMDA
Omada Health, Inc.
May 18, 2026 BUY Strong Buy
+32.0% avg upside
11 analysts
$30.00
70.08% Upside
+6.1%
DOCS
Doximity
May 14, 2026 BUY Buy
+61.4% avg upside
27 analysts
$35.00
71.16% Upside
+14.8%
CERT
Certara
May 12, 2026 HOLD Buy
+133.5% avg upside
21 analysts
$10.00
80.42% Upside
+18.9%
HIMS
Hims & Hers Health
May 12, 2026 HOLD Buy
-27.8% avg upside
22 analysts
$21.00
40.83% Downside
+8.6%
LFST
Lifestance Health Group
May 07, 2026 BUY Strong Buy
+8.4% avg upside
14 analysts
$10.00
11.45% Upside
-2.7%
AMWL
American Well
May 06, 2026 HOLD Hold
+64.6% avg upside
15 analysts
$6.50
22.90% Downside
+5.0%
GDRX
GoodRx Holdings
Feb 27, 2026 HOLD Buy
+387.3% avg upside
28 analysts
$3.00
12.70% Upside
+39.6%
SLAB
Silicon Laboratories
Feb 06, 2026 HOLD Hold
-12.8% avg upside
20 analysts
$231.00
5.12% Upside
+6.0%
HCA
HCA Healthcare
Jan 28, 2026 SELL Buy
+14.7% avg upside
35 analysts
$425.00
13.36% Upside
+20.7%
DH
Definitive Healthcare Corp
Dec 18, 2025 HOLD Buy
+660.4% avg upside
19 analysts
$3.50
360.55% Upside
-67.2%
SWKS
Skyworks Solutions
Nov 04, 2022 HOLD Buy
+11.3% avg upside
38 analysts
$96.00
32.52% Upside
+6.2%
TXN
Texas Instruments
Jan 26, 2022 SELL Buy
-25.8% avg upside
48 analysts
$198.00
38.59% Downside
-0.4%
AVGO
Broadcom
Sep 03, 2021 BUY Strong Buy
+6.6% avg upside
51 analysts
$572.00
39.14% Upside
+3.4%
TEL
TE Connectivity
Jul 29, 2021 HOLD Strong Buy
-1.7% avg upside
25 analysts
$138.00
36.66% Downside
-7.2%
APH
Amphenol
Jul 29, 2021 HOLD Strong Buy
-8.9% avg upside
18 analysts
$75.00
54.18% Downside
+8.3%
SYNA
Synaptics
May 07, 2021 BUY Strong Buy
-11.5% avg upside
26 analysts
$185.00
31.32% Upside
+22.3%
MCHP
Microchip
May 07, 2021 BUY Strong Buy
+4.4% avg upside
33 analysts
$88.50
11.22% Downside
-8.7%
QRVO
Qorvo
May 06, 2021 BUY Hold
+4.8% avg upside
36 analysts
$223.00
126.56% Upside
-42.0%
ON
ON Semiconductor
May 04, 2021 SELL Buy
-14.2% avg upside
43 analysts
$32.00
73.66% Downside
-58.2%
ST
Sensata
Apr 28, 2021 BUY Buy
+0.9% avg upside
21 analysts
$73.00
44.26% Upside
-21.7%
NXPI
NXP Semiconductors
Apr 26, 2021 HOLD Strong Buy
-14.2% avg upside
35 analysts
$213.00
31.93% Downside
-17.1%
PI
IMPINJ
Feb 11, 2021 HOLD Strong Buy
+12.4% avg upside
16 analysts
$58.00
54.86% Downside
+0.2%
ADI
Analog Devices
Jun 16, 2020 HOLD Strong Buy
-16.6% avg upside
41 analysts
$117.00
73.15% Downside
+37.8%
NVDA
Nvidia
Oct 22, 2019 HOLD Strong Buy
+28.0% avg upside
70 analysts
$180.00
14.65% Downside
+173.7%
INTC
Intel
Jul 12, 2017 HOLD Buy
-45.8% avg upside
65 analysts
$38.00
71.61% Downside
+56.9%
AMD
Advanced Micro Devices
Jul 19, 2016 SELL Strong Buy
-27.0% avg upside
58 analysts
-150.5%
AMBA
Ambarella
Jul 19, 2016 BUY Strong Buy
+49.0% avg upside
26 analysts
-10.7%
PLXS
Plexus
Nov 08, 2012 HOLD Buy
-47.8% avg upside
14 analysts
$22.00
92.62% Downside
+77.8%
FLEX
Flex
Aug 07, 2012 BUY Strong Buy
-26.5% avg upside
18 analysts
$8.00
94.63% Downside
+33.4%
JBL
Jabil
Jun 20, 2012 BUY Strong Buy
-21.3% avg upside
17 analysts
$25.00
93.33% Downside
-1.4%
ARW
Arrow Electronics
Aug 08, 2011 HOLD Buy
-43.2% avg upside
12 analysts
$33.00
85.76% Downside
+28.5%
SANM
Sanmina-Sci
Sep 17, 2010 HOLD Hold
-43.2% avg upside
11 analysts
-28.7%
🔒 34 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Craig Hettenbach — Frequently Asked Questions
How accurate are Craig Hettenbach's stock ratings?
Based on the calls 13Foresight could measure, about 55% of Craig's ratings were profitable over a one-year hold, with an average return of +3.4% per rating, or -3.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Craig ranked on 13Foresight?
Craig Hettenbach is currently ranked #1494 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Craig cover?
Craig most recently has ratings on THC, HNGE, GMRS, ARDT, VEEV, WAY, UHS, OMDA, DOCS, CERT, HIMS, LFST and 27 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.